ABO and platelet transfusion therapy
By:
Paid access
|Apr 2020References
- Murphy S. ABO blood groups and platelet transfusion. Transfusion 1988;28:401–2.
- Aster RH. Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood 1965;26:732–43.
- Herman JH. Apheresis platelet transfusions: does ABO matter? Transfusion 2004;44:802–4.
- Benjamin RJ, Antin JH. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion 1999;39:1273–4.
- Lapierre V, Mahe C, Auperin A, et al. Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children. Transplantation 2005;80:314–9.
- Mollicone R, Caillard T, Pendu JL, et al. Expression of ABH and X (LeX) antigens on platelets and lymphocytes. Blood 1988;71:1113–9.
- Santoso S, Kiefel V, Mueller-Eckhardt C. Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib. Thromb Haemostasis 1991;65:196–201.
- Stockelberg D, Hou M, Rydberg L, Kutti J, Wadenvik H. Evidence for an expression of blood group A antigen on platelet glycoproteins IV and V. Transfus Med 1996;6:243–8.
- Kelton JG, Smith JW, Horsewood P, et al. ABH antigens on human platelets: expression on the glycosyl phosphatidylinositol-anchored protein CD109. J Lab Clin Med 1998;132:142–8.
- Cooling LLW, Kelly K, Barton J, et al. Determinants of ABH expression on human blood platelets. Blood 2005;105:3356–64.
- Tsuji T, Osawa T. Structures of the carbohydrate chains of membrane glycoproteins IIb and IIIa of human platelets. J Biochem 1986;100:1387–98.
- Julmy F, Achermann F, Schulzki T, Carrel T, Nydegger U. Platelets of blood group A1 donors express increased surface A antigen owing to apheresis and prolonged storage. Transfusion 2003;43:1378–85.
- Devine V, Thon J, Schubert P, Serrano K, Kast J. Application of proteomics methods to the analysis of the platelet storage lesion. Vox Sang 2006; 91(Suppl 3): S34.
- Kelton JG, Hamid C, Aker S, Blajchman M. The amount of blood group A substance on platelets is proportional to the amount in the plasma. Blood 1982;59:980.
- Dunstan RA, Mansbach CM. Biochemical characterization of A blood group activity on human platelets. Vox Sang 1985;49:149–53.
- Holgersson J, Breimer ME, Jacobsson A, et al. Glycolipid- and glycoprotein-based blood group A antigen expression in human thrombocytes. A1/A2 difference. Glycoconjugate J 1990;7:601–8.
- Koerner TAW, Weinfeld HM, Bullard LSB, Williams LCJ. Antibodies against platelet glycosphingolipids: detection in serum by quantitative HPTLC-autoradiography and association with autoimmune and alloimmune processes. Blood 1989; 74:274–84.
- Cooling LLW, Zhang D, Koerner TAW. Human platelets express gangliosides with LKE activity and ABH blood group activity. Transfusion 2001;41:504–16.
- Holgersson J, Breimer ME, Samuelsson BE. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids. APMIS Suppl 1992;27:18–27.
- Stults CL, Sweeley CC, Macher BA. Glycosphingolipids: structure, biological source, and properties. Methods Enzymol 1989;179:167–214.
- Dunstan RA, Simpson MB, Knowles RW, Rosse WF. The origin of ABH antigens on human platelets. Blood 1985;65:615–9.
- Cao Y, Merling A, Karsten U, Schwartz-Albiez R. The fucosylated histo-blood group antigen H (type 2 blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+ hematopoietic progenitors but absent on mature lymphocytes. Glycobiology 2001;11:677–83.
- Hosoi E, Hirose M, Hamano S. Expression levels of H-type (1,2)-fucosyltransferase gene and histoblood group ABO gene corresponding to hematopoietic cell differentiation. Transfusion 2003;43:65–71.
- Okumura M, Morishima Y, Michinori O, et al. Expression of H-related antigen on human megakaryocytes and megakaryocytic leukemic cells. Int J Hematol 1991;54:151–8.
- Schmitz B, Thiele J, Otto F, et al. Interactions between endogenous lectins and fucosylated oligosaccharides in megakaryocyte-dependent fibroblast growth of the normal bone marrow. Leukemia 1996;10:1604–14.
- Sweegman S, Veenhof MA, Huijgens PC, Schuurhuis GJ, Drager AM. Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation. Exp Hematol 2000;28:401–10.
- Han P, Guo XH, Story CJ. Enhanced expansion and maturation of megakaryocytic progenitors by fibronectin. Cytotherapy 2002;4:277–83.
- Mossuz P, Schweitzer A, Molla A, Berthier R. Expression and function of receptors for extracellular matrix molecules in the differentiation of human megakaryocytes in vitro. Br J Haematol 1997;98:819–27.
- Molla A, Mossuz P, Berthier R. Extracellular matrix receptors and the differentiation of human megakaryocytes in vitro. Leuk Lymphoma 1999;33:15–23.
- Ichikawa D, Handa K, Hakomori SI. Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancy. Int J Cancer 1998;76:284–9.
- Ichikawa D, Handa K, Withers DA, Hakomori SI. Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: approach with A and B gene transfection. Cancer Res 1997;57:3092–6.
- Groupille C, Marionneau S, Bureau V, et al. 1,2-fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells. Glycobiology 2000;10:375–82.
- Hoffman S, Zhou L, Gu Y, Davenport R, Cooling L. Delayed platelet engraftment in group O patients after autologous progenitor cell transplantation. Transfusion 2005;45:885–95.
- Skogen B, Rossenbo Hansen B, Husebekk A, Havnes T, Hannestad K. Minimal expression of blood group A antigen on thrombocytes from A2 individuals. Transfusion 1988;28:456–9.
- Curtis BR, Edwards JT, Hessner MJ, Klein JP, Aster RH. Blood group A and B antigens are strongly expressed on platelets of some individuals. Blood 2000;96:1574–81.
- Heal JM, Mullin A, Blumberg N. The importance of ABH antigens in platelet crossmatching. Transfusion 1989;29:514–20.
- Ogasawara K, Ueki J, Takenaka M, Furihata K. Study on the expression of ABH antigens on platelets. Blood 1993;82:993–9.
- Jimenez TM, Patel SB, Pineda AA, Tefferi A, Owen WG. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility. Transfusion 2003;43:328–34.
- Heal JM, Blumberg N, Masel D. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood 1987;70:23–30.
- Schlichter SJ, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005;105:4106–14.
- Brand A, Sintnicolaas K, Claas FH, Eernisse JG. ABH antibodies causing platelet transfusion refractoriness. Transfusion 1986;26:463–6.
- Friedberg RC, Donnelly SF, Boyd JC, Gray LS, Mintz PD. Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood 1993;81:3428–34.
- Lee EJ, Schiffer CA. ABO compatibility can influence the results of platelet transfusion. Transfusion 1989;29:384–9.
- Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 1990;75:408–13.
- Ishibashi M, Oshida M, Kurata Y, et al. Immunologic low-responder in ABO-incompatible renal transplant recipients explored by donor-specific platelet transfusion. Transplant Proc 1998;30: 2298–9.
- Heal JM, Masel D, Blumberg N. Interaction of platelet Fc and complement receptors with circulating immune complexes involving the ABO system. Vox Sang 1996;71:205–11.
- Heal JM, Masel D, Rowe JM, Blumberg N. Circulating immune complexes involving the ABO system after platelet transfusion. Br J Haematol 1993;566–72.
- Duquesnoy RJ, Anderson AJ, Tomasulo PA, Aster RH. ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood 1979;54:595–9.
- Ellinger PJ, Morgan LK, Malecek AC, Chaplin H. Effect of ABO mismatching on a radioimmunoassay for platelet compatibility. Successful adsorption of ABO alloantibodies with synthetic A and B substance. Transfusion 1989;29:134–8.
- Blumberg N, Heal JM, Rapoport A, et al. Effect of ABO-identical platelets and leukodepletion on blood utilization and costs of autologous marrow transplantation (abstract). Transfusion 1993;33: A15.
- Heal JM, Rowe JM, Blumberg N. ABO and platelet transfusion revisited. Ann Hematol 1993;66: 309–14.
- Blumberg N, Heal JM, Kirkley SA, et al. Leukodepleted-ABO identical blood components in the treatment of hematologic malignancies: a cost analysis. Am J Hematol 1995;48:108–15.
- Heal JM, Kenmotsu N, Rowe JM, Blumberg N. A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions. Am J Hematol 1994;45:189–90.
- Heal JM, Blumberg N. Optimizing platelet transfusion therapy. Blood Rev 2004;18:149–65.
- Blumberg N, Heal JM, Hicks GL, Risher WH. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion 2001;41:790–3.
- Blumberg N, Heal JM. ABO-mismatched platelet transfusions and clinical outcomes after cardiac surgery (letter). Transfusion 2002;42:1527–9.
- Lin Y, Callum JL, Coovadia AS, Murphy PM. Transfusion of ABO-nonidentical platelets is not associated with adverse clinical outcomes in cardiovascular surgery patients. Transfusion 2002;42:166–72.
- Badros A, Tricot G, Toor A, et al. ABO mismatch may effect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion 2002;42:205–9.
- Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999;39:179–87.
- Stussi G, Halter J, Schanz U, Seebach JD. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation. Transfus Apheresis Sci 2006;35:59–69.
- Brecher ME, ed. Technical manual, 15th ed. Bethesda, MD: American Association of Blood Banks, 2005.
- Gordon B, Tarantolo S, Ruby E, et al. Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 1998;22: 999–1003.
- West L, Pollock-Barziv SM, Diphanc AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001;344:793–800.
- Stegall MD, Dean PG, Gloor JM. ABO-incompatible kidney transplantation. Transplantation 2004;78: 635–40.
- Zoes C, Dube VE, Miller HJ, Vye MV. Anti-A1 in the plasma of platelet concentrates causing a hemolytic reaction. Transfusion 1977;17:29–32.
- McLeod BC, Sassetti RJ, Weens JH, Vaithianathan T. Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrate. Scand J Haematol 1982;28:193–6.
- Conway LT, Scott EP. Acute hemolytic transfusion reaction due to ABO incompatible plasma in a platelet apheresis concentrate (letter). Transfusion 1984;24:413–4.
- Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion 1985;25:60–2.
- Ferguson DJ. Acute intravascular hemolysis after a platelet transfusion. Can Med Assoc J 1988;138: 523–4.
- Reis MD, Coovadia AS. Transfusion of ABO-incompatible platelets causes severe haemolytic reaction. Clin Lab Haematol 1989;11:237–40.
- Murphy MF, Hook S, Waters AH, et al. Acute haemolysis after ABO-incompatible platelet transfusions (letter). Lancet 1990;335:974–5.
- Chow M-P, Yung C-H, Hu H-Y, Tzeng C-H. Hemolysis after ABO-incompatible platelet transfusion. Chin Med J (Taipei) 1991;48:131–4.
- Mair B, Benson K. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion 1998;38:51–5.
- McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incompatible platelet products. Am J Clin Pathol 1999;111:202–6.
- Duguid JKM, Minards J, Bolton-Maggs PHB. Lesson of the week: incompatible plasma transfusions and haemolysis in children. Br Med J 1999;318: 176–7.
- Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000;40:902–6.
- Valbonesi M, De Luigi MC, Lercari G, et al. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. Int J Artif Organs 2000;23:642–6.
- Sauer-Heilborn A, Jahagirdar B, Burns L, Scofield T, Nollet KE. Passive antibody, aggressive hemolysis: an ABO-incompatible platelet transfusion (abstract). Transfusion 2002;42(Suppl): SP304.
- Reducing supernatant plasma of pooled platelets before administration to ABO-incompatible recipients. CBBS, e-network forum. Available at: http:// www.cbbsweb.org/enf/2002/pltpoolplasma.html.
- Gresens C, Gloster E, Wang L, Dimaio T. Acute hemolysis in a group A trauma patient who received a group O plateletpheresis unit (abstract). Transfusion 2003;43(Suppl): SP234.
- Yeast JD, Plapp F. Fetal anemia as a response to prophylactic platelet transfusion in the management of alloimmune thrombocytopenia. Am J Obstet Gynecol 2003;189:874–6.
- Ozturk A, Turken O, Sayan O, Atasoyu EM. Acute intravascular hemolysis due to ABO-incompatible platelet transfusion. Acta Haematol 2003;110: 211–2.
- What is the frequency of hemolytic reactions associated with transfusion of plateletpheresis units containing ABO incompatible plasma. CBBS, e-network forum. Available at: http://www. cbbsweb.org/enf/2003/plt_aborxnfreq.html.
- Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have “high-titer” anti-A/A, B: implications for transfusion policy. Transfusion 2004;44:805–8.
- Angiolillo A, Luban NLC. Hemolysis following an out-of-group platelet transfusion in an 8-month-old with Langerhans cell histiocytosis. J Pediatr Hematol Oncol 2004;26:267–9.
- Sapatnekar S, Sharma G, Downes KA, Wiersma S, McGrath C, Yomtovian R. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets. J Clin Apheresis 2005;20:225–9.
- Sadani DT, Urbaniak SJ, Bruce M, Tighes JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transf Med 2006;16:375–9.
- Lozano M, Cid J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003;17: 57–68.
- Pietersz RNI, Engelfriet CP. Transfusion of apheresis platelets and ABO groups. Vox Sang 2005;88: 207–21.
- College of American Pathology. Transfusion Medicine Survey (J-A). 2005.
- Schwartz J, Delpalma H, Kapoor K, Hamilton T, Grima K. Anti-A titers in group O single donor platelets: to titer or not to titer (abstract). Transfusion 2003;43(Suppl): SP247.
- Oza KK. ABO mismatched platelet transfusion and acute intravascular hemolysis (abstract). Transfusion 2002;42(Suppl): SP308.
- Wagner F, Adamo W. Reduced rate of adverse reactions to plasma reduced pooled platelet units: possible role of minor incompatible transfusion (abstract). Vox Sang 2006;91(Suppl 3): P508.
- Shanwell A, Ringden O, Wiechel B, Rumin S, Akerblom O. A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplant recipients. Vox Sang 1991;60:23–7.
- Mollison PL, Engelfriet CP, Contreras M, ed. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Science, 1997.
- Boothe G, Brecher ME, Root M, Robinson J, Haley R. Acute hemolysis due to passively transfused high-titer anti-B causing spontaneous in vitro agglutination. Immunohematology 1995;11:43–5.
- The practice of transfusing out-of-type platelets. CBBS, e-network forum. Available at: http://www. cbbsweb.org/enf/2002/plttx_aboincompat.html.
- de Wildt-Eggen J, Gulliksson H. In vivo and in vitro comparison of platelets stored in either synthetic media or plasma. Vox Sang 2003;84:256–64.
- Ringwald J, Zimmerman R, Eckstein R. The new generation of platelet additive solution for storage at 22°C: development and current experience. Transfus Med Rev 2006;20:158–64.
- de Wildt-Eggen J, Nauta S, Schrijver JG, van Marwijk Kooy M, Bins M, van Prooijen HC. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 2000;40:398–403.
- References on patient outcomes following transfusion of ABO incompatible platelets. CBBS, e-network forum. Available at: http//www. cbbsweb.org/enf/outcome_aboinc_plt.html.
- Chambers LA. Transfusion of plasma and platelets to neonates. In: Herman JH, Manno CS, eds. Pediatric transfusion therapy, 2002. Bethesda, MD: AABB Press, 2002:93–107.
DOI: https://doi.org/10.21307/immunohematology-2019-314 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 20 - 33
Published on: Apr 1, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2020 L. Cooling, published by American National Red Cross
This work is licensed under the Creative Commons License.